BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21872901)

  • 1. Protein kinase biochemistry and drug discovery.
    Schwartz PA; Murray BW
    Bioorg Chem; 2011 Dec; 39(5-6):192-210. PubMed ID: 21872901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical kinomics: a powerful strategy for target deconvolution.
    Kim DH; Sim T
    BMB Rep; 2010 Nov; 43(11):711-9. PubMed ID: 21110913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.
    Cox KJ; Shomin CD; Ghosh I
    Future Med Chem; 2011 Jan; 3(1):29-43. PubMed ID: 21428824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
    Bogoyevitch MA; Fairlie DP
    Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the putative catalytic base in the phosphoryl transfer reaction in a protein kinase: first-principles calculations.
    Valiev M; Kawai R; Adams JA; Weare JH
    J Am Chem Soc; 2003 Aug; 125(33):9926-7. PubMed ID: 12914447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural biology contributions to tyrosine kinase drug discovery.
    Cowan-Jacob SW; Möbitz H; Fabbro D
    Curr Opin Cell Biol; 2009 Apr; 21(2):280-7. PubMed ID: 19208462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteus in the world of proteins: conformational changes in protein kinases.
    Rabiller M; Getlik M; Klüter S; Richters A; Tückmantel S; Simard JR; Rauh D
    Arch Pharm (Weinheim); 2010 Apr; 343(4):193-206. PubMed ID: 20336692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the catalytic mechanism of the p21-activated protein kinase PAK2.
    Wu H; Zheng Y; Wang ZX
    Biochemistry; 2003 Feb; 42(4):1129-39. PubMed ID: 12549935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical approaches towards unravelling kinase-mediated signalling pathways.
    Hodgson DR; Schröder M
    Chem Soc Rev; 2011 Mar; 40(3):1211-23. PubMed ID: 21152652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool.
    Åberg E; Lund B; Pflug A; Gani OA; Rothweiler U; de Oliveira TM; Engh RA
    Biol Chem; 2012 Oct; 393(10):1121-9. PubMed ID: 23092797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model?
    Adams JA
    Biochemistry; 2003 Jan; 42(3):601-7. PubMed ID: 12534271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.
    Romaker D; Schregel V; Maurer K; Auerochs S; Marzi A; Sticht H; Marschall M
    J Med Chem; 2006 Nov; 49(24):7044-53. PubMed ID: 17125257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the inhibition of protein kinases.
    Brockhoff M; Hau JC; Fontana P; Zimmermann C; Pover AD; Erdmann D; Chène P
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):194-200. PubMed ID: 21635207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic mechanisms and regulation of protein kinases.
    Wang Z; Cole PA
    Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doing more than just the structure-structural genomics in kinase drug discovery.
    Marsden BD; Knapp S
    Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
    Chuaqui C; Deng Z; Singh J
    J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structural atlas of kinases inhibited by clinically approved drugs.
    Wang Q; Zorn JA; Kuriyan J
    Methods Enzymol; 2014; 548():23-67. PubMed ID: 25399641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophosphorylation kinetics of protein kinases.
    Wang ZX; Wu JW
    Biochem J; 2002 Dec; 368(Pt 3):947-52. PubMed ID: 12190618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.